NM_005458.8:c.2052C>T
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_005458.8(GABBR2):c.2052C>T(p.Pro684Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.165 in 1,613,292 control chromosomes in the GnomAD database, including 22,495 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.17 ( 2178 hom., cov: 33)
Exomes 𝑓: 0.16 ( 20317 hom. )
Consequence
GABBR2
NM_005458.8 synonymous
NM_005458.8 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.14
Publications
16 publications found
Genes affected
GABBR2 (HGNC:4507): (gamma-aminobutyric acid type B receptor subunit 2) The multi-pass membrane protein encoded by this gene belongs to the G-protein coupled receptor 3 family and GABA-B receptor subfamily. The GABA-B receptors inhibit neuronal activity through G protein-coupled second-messenger systems, which regulate the release of neurotransmitters, and the activity of ion channels and adenylyl cyclase. This receptor subunit forms an active heterodimeric complex with GABA-B receptor subunit 1, neither of which is effective on its own. Allelic variants of this gene have been associated with nicotine dependence.[provided by RefSeq, Jan 2010]
GABBR2 Gene-Disease associations (from GenCC):
- developmental and epileptic encephalopathy, 59Inheritance: AD Classification: STRONG, MODERATE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- neurodevelopmental disorder with poor language and loss of hand skillsInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- atypical Rett syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 9-98306298-G-A is Benign according to our data. Variant chr9-98306298-G-A is described in ClinVar as Benign. ClinVar VariationId is 1167956.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.14 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.2 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| GABBR2 | NM_005458.8 | c.2052C>T | p.Pro684Pro | synonymous_variant | Exon 15 of 19 | ENST00000259455.4 | NP_005449.5 | |
| GABBR2 | XM_017015331.3 | c.1758C>T | p.Pro586Pro | synonymous_variant | Exon 14 of 18 | XP_016870820.1 | ||
| GABBR2 | XM_005252316.6 | c.1278C>T | p.Pro426Pro | synonymous_variant | Exon 13 of 17 | XP_005252373.1 | ||
| GABBR2 | XM_017015332.3 | c.1278C>T | p.Pro426Pro | synonymous_variant | Exon 12 of 16 | XP_016870821.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.166 AC: 25174AN: 152084Hom.: 2181 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
25174
AN:
152084
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.170 AC: 42575AN: 251022 AF XY: 0.172 show subpopulations
GnomAD2 exomes
AF:
AC:
42575
AN:
251022
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.164 AC: 240257AN: 1461090Hom.: 20317 Cov.: 33 AF XY: 0.166 AC XY: 120679AN XY: 726900 show subpopulations
GnomAD4 exome
AF:
AC:
240257
AN:
1461090
Hom.:
Cov.:
33
AF XY:
AC XY:
120679
AN XY:
726900
show subpopulations
African (AFR)
AF:
AC:
5675
AN:
33464
American (AMR)
AF:
AC:
8617
AN:
44684
Ashkenazi Jewish (ASJ)
AF:
AC:
3398
AN:
26128
East Asian (EAS)
AF:
AC:
6920
AN:
39696
South Asian (SAS)
AF:
AC:
18289
AN:
86218
European-Finnish (FIN)
AF:
AC:
7132
AN:
53412
Middle Eastern (MID)
AF:
AC:
1538
AN:
5766
European-Non Finnish (NFE)
AF:
AC:
178396
AN:
1111350
Other (OTH)
AF:
AC:
10292
AN:
60372
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
10694
21387
32081
42774
53468
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
6528
13056
19584
26112
32640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.165 AC: 25177AN: 152202Hom.: 2178 Cov.: 33 AF XY: 0.165 AC XY: 12267AN XY: 74418 show subpopulations
GnomAD4 genome
AF:
AC:
25177
AN:
152202
Hom.:
Cov.:
33
AF XY:
AC XY:
12267
AN XY:
74418
show subpopulations
African (AFR)
AF:
AC:
7108
AN:
41528
American (AMR)
AF:
AC:
2923
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
454
AN:
3470
East Asian (EAS)
AF:
AC:
896
AN:
5172
South Asian (SAS)
AF:
AC:
1017
AN:
4826
European-Finnish (FIN)
AF:
AC:
1413
AN:
10594
Middle Eastern (MID)
AF:
AC:
64
AN:
294
European-Non Finnish (NFE)
AF:
AC:
10738
AN:
68006
Other (OTH)
AF:
AC:
393
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1112
2224
3335
4447
5559
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
280
560
840
1120
1400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
588
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Neurodevelopmental disorder with poor language and loss of hand skills Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Epileptic encephalopathy Benign:1
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Developmental and epileptic encephalopathy, 59 Benign:1
Aug 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.